Clinical trial
Study of Intravenous Amino Acid Infusion to Prevent Contrast Dye Mediated Renal…
NCT00313807 · Queen's University, Other · Withdrawn
Key facts
| NCT number | NCT00313807 |
|---|---|
| Title | Study of Intravenous Amino Acid Infusion to Prevent Contrast Dye Mediated Renal Damage |
| Official title | CoNTRST - Contrast Nephropathy and Travasol for Renal Safety Trial: Intravenous Amino Acid Infusion for the Prevention of Contrast-mediated Acute Renal Failure Following Coronary Catheterization |
| Lead sponsor | Queen's University, Other |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Contrast Nephropathy, Renal Failure |
| Intervention type | Drug |
| Interventions | Amino Acid, Placebo |
| Enrollment | 0 |
| Start date | Nov 1, 2005 |
| Completion | Sep 1, 2008 |
| First posted | Apr 12, 2006 |
| Last update posted | Mar 11, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: